Bio-Rad Laboratories | BIO - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Abbott USD 168.02B 10.39B 2026-04
Agilent USD 37.86B 3.64B 2025-12
Becton, Dickinson and Co. USD 55.29B 1.64B 2025-12
Bio Techne USD 9.16B 502M 2025-12
Bio-Rad Laboratories USD 6.35B 1.86B 2026-04
Bruker USD 7.16B 2.23B 2025-12
Charles River Laboratories USD 10.02B 2.71B 2025-12
Danaher USD 130.07B 1.61B 2026-04
General Electric Aerospace USD 304.21B 7.72B 2026-04
Illumina USD 19.95B 670M 2026-04
IQVIA Holdings USD 29.18B 9.2B 2026-04
Laboratory Of America USD 21.88B 1.08B 2026-04
Merck USD 279.96B 18.7B 2026-04
Mettler Toledo International USD 28.48B 3.19B 2025-12
Myriad Genetics USD 575M 98M 2025-12
OraSure Technologies USD 174M 61M 2025-12
Pacific Biosciences Of California USD 565M 180M 2025-12
Quest Diagnostics USD 22.04B 348M 2026-04
Repligen USD 9.22B 1.7B 2025-12
Revvity USD 10.97B 1.21B 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Siemens EUR 191.32B 7.96B 2025-12
Standard Biotools USD 492M 5M 2025-12
Thermo Fisher Scientific USD 177.96B 4.7B 2026-04
Tosoh JPY 764.59B 52.83B 2025-12
Waters USD 22.61B 5.25B 2025-12